Benzodiazepines ‘do not increase dementia risk’

social-anxiety DALLAS: Benzodiazepines are a class of drugs that increase the level of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, producing sedative, anti-convulsant, anti-anxiety, hypnotic and muscle relaxant effects.

Benzodiazepines are most commonly used to treat anxiety and insomnia, though they are used for a number of other conditions, including alcohol withdrawal, panic disorders and seizures. Common types of benzodiazepines include diazepam, alprazolam and flurazepam.

In the US, benzodiazepine use is highest among older individuals; a 2014 study from the National Institutes of Health (NIH) found that around 8.7% of adults aged 65-80 received a benzodiazepine prescription in 2008, compared with 2.6% of those aged 18-35.

Numerous studies, however, have associated benzodiazepine use in seniors with increased risk of dementia.

However, Gray and colleagues note that research assessing benzodiazepine use in older adults has been conflicting, with some studies finding no link with dementia.

“Given the enormous public health implications, we need a better understanding of the potential cognitive risks of cumulative benzodiazepine use,” say the authors…

Full story covered in the Dementia Business Weekly.